Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| BioNexus Gene Lab Corporation (PK) | BGLC | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.91 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.91 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 1.845 - 17.88 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.91 | USD |
BioNexus Gene Lab Corporation (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 158.08M | 173.72M | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BioNexus Gene Lab (PK) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/15/2024 | 12:20 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 4/18/2024 | 12:44 | Edgar (US Regulatory) | Form 8-K - Current report |
| 4/16/2024 | 12:00 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 4/01/2024 | 14:59 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/28/2024 | 14:59 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form.. |
| 3/26/2024 | 14:59 | Edgar (US Regulatory) | Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:.. |
| 11/20/2023 | 16:10 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 11/13/2023 | 12:40 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/30/2023 | 11:14 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 10/16/2023 | 09:04 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/11/2023 | 09:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/04/2023 | 14:57 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BGLC Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 2.688 | 17.88 | 1.845 | 10.55 | 181,931 | -1.78 | -66.15% |
| 3 Years | 12.12 | 27.00 | 0.96 | 10.14 | 16,039 | -11.21 | -92.49% |
| 5 Years | 4.32 | 40.20 | 0.96 | 10.41 | 12,241 | -3.41 | -78.94% |
BioNexus Gene Lab (PK) Description
| We are an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. We were incorporated in the State of Wyoming on May 12, 2017. On August 23, 2017, we acquired all of the outstanding capital stock of BioNexus Gene Lab Sdn Bhd., a Malaysian corporation ("Subsidiary"). The Subsidiary was incorporated in Malaysia on April 7, 2015. The Subsidiary owns algorithm software, technology and know how related to the detection of common diseases through blood analysis which we use in our business. On December 31, 2020, the company consummated a Share Exchange Agreement with Chemrex Corporation Sdn Bhd (Chemrex) and acquired all of the issued and outstanding shares of capital stock of Chemrex. Chemrex,, a Malaysian company incorporated in Malaysia on September 29, 2004 |
